Research

Presentations

  1. Annual Advances in Immuno-Oncology USA Congress: Ian Wilson, CEO, presentation titled, “Insights on Reverse Translation for Patient Stratification in Clinical Studies”. Presented Wednesday, October 9, 2019
  2. Annual Advances in Immuno-Oncology USA Congress: Ian Wilson, CEO, chaired a Panel Discussion titled, “Technological Challenges in Clinical Studies”. Presented Wednesday, October 9, 2019
  3. Annual Advances in Immuno-Oncology USA Congress hosted by Oxford Global: Ivan Plavec, CBO, webinar titled, “How CD8 Imaging is Useful to Pharma Regarding Drug Research and Clinical Decision Making”. Presented Thursday, August 29, 2019
  4. SNMMI 2019: Abhinay Joshi gave poster presentation titled, “PET scanner harmonization for multi-center clinical trials using 89Zr  tracers in partnership with Clinical Trials Network (CTN)”. Presented Tuesday, June 25, 2019
  5. SNMMI 2019: Ian Wilson, CEO, presentation titled, “Imaging the Immune System: CD8+ and Beyond ” during the CMIT Emerging Technologies session: Emerging  Technologies — A Look into the Future of Molecular Imaging and Therapy”. Presented Sunday, June 23, 2019
  6. BioEquity Europe 2019: Ian Wilson, CEO, panelist on Panel Discussion titled, “Technologies and Treatments — What’s on the horizon”. Presented Thursday, May 9, 2019
  7. SITC 2018: Poster and Oral presentation by Michael Gordon on ImaginAb’s Phase I study, titled, “Imaging of tumor-infiltrating T cells with an anti-CD8 minibody 89Zr-IAB22M2C in advanced solid tumors: A phase I first-in-human study”. Presented Friday, November 9, 2018
  8. WMIC 2018: Tove Olafsen poster presentation titled, “Tracking CD8+ T cells in the Tumor Microenvironment: Development of 89Zr-Df-IAB22M2C, an ImmunoPET Probe for Clinical Immunotherapy Applications”. Presented Friday, September 14, 2018
  9. SITC 2018: Meeting Abstracts published in Journal for ImmunoTherapy of Cancer 2018 6(Suppl 2):434, Published: December 6, 2018
  10. SNMMI 2018: Wolfgang Weber gave oral presentation titled, “First-in-Human Phase I Imaging Study with 89Zr-Df-IAB22M2C anti-CD8 minibody in Patients with Solid Tumors”. Presented Saturday, June 23, 2018
  11. ASCO 2018: Jedd Wolchok presented CD8 PET images from Phase I study as a part of his talk titled, “Immune-Related Response and RECIST in Radiographic Imaging”. Presented Saturday, June 2, 2018
  12. IO360 2018: Ron Korn presented CD8 PET images from Phase I study as a part of his talk titled, “Use of Imaging Biomarkers for Immunotherapy”. Presented Wednesday, Feb 7, 2018